There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

(MENAFN- Daily News Egypt) Iran plans to unveil a new anti-cancer vaccine in the summer of 2025, according to the institute established under the supervision of the Iranian Ministry of Science ...

"This strong and durable activation in T cells was encouraging and indicates that we're able to generate a long-lasting, anti-cancer immune response with the vaccine," Braun explained. The ...

“This strong and durable activation in T cells was encouraging and indicates that we're able to generate a long-lasting, anti-cancer immune response with the vaccine,” Braun explaine ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...